Arbutus Biopharma Corp (ABUS) - NASDAQ
From other sites
Company Description
Arbutus Biopharma Corp. is a biopharmaceutical company, which focuses on on discovering, developing and commercializing a cure for patients suffering from chronic HBV infection, a disease of the liver caused by the hepatitis B virus. The company was founded on October 6, 2005 and is... More
Sector: Healthcare
Industry: Diagnostic Substances
Country: United States